Upstream Bio, Inc. (UPB) stock
UPBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.10−0.05 (-2.33%)
Close on Nov 17, 2026Market cap $115.02MP/E –Yield –
Upstream Bio price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Upstream Bio's price to sales ratio was 55.5× on Nov 11, 2026, against 357.7× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 55.5× | −316.1 |
| 2025 | Sep 30, 2025 | 371.6× | +349.1 |
| 2024 | Dec 31, 2024 | 22.5× | – |
See a number that looks wrong?